Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation

Particle and Fibre Toxicology

Volumn 11, Issue 1, 2014, Pages

  Thompson, Joyce K ^a   Westbom, Catherine M ^a   MacPherson, Maximilian B ^a   Mossman, Brooke T ^a   Heintz, Nicholas H ^a   Spiess, Page ^a   Shukla, Arti ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Asbestos; Inflammasomes; Malignant mesothelioma; Thioredoxin; Thioredoxin interacting protein

Indexed keywords

CROCIDOLITE; DEHYDROASCORBIC ACID; INFLAMMASOME; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; THIOREDOXIN 1; THIOREDOXIN INTERACTING PROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOSYNTHESIS; CARCINOGENESIS; CELL LEVEL; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SURVIVAL TIME;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; ASBESTOS, CROCIDOLITE; BLOTTING, WESTERN; CASPASE 1; CELL LINE, TUMOR; DEHYDROASCORBIC ACID; DINITROCHLOROBENZENE; ENZYME ACTIVATION; EPITHELIUM; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLAMMATION; L-LACTATE DEHYDROGENASE; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; THIOREDOXIN REDUCTASE 1; THIOREDOXINS;

EID: 84902259891     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-11-24     Document Type: Article

References (43)

1. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998, 157:1666-1680. 10.1164/ajrccm.157.5.9707141, 9603153.
2. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005, 353:1591-1603. 10.1056/NEJMra050152, 16221782.
3. Goldberg JL, Zanella CL, Janssen YM, Timblin CR, Jimenez LA, Vacek P, Taatjes DJ, Mossman BT. Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos. Am J Respir Cell Mol Biol 1997, 17:265-271. 10.1165/ajrcmb.17.3.2991, 9308911.
4. Shukla A, Ramos-Nino M, Mossman B. Cell signaling and transcription factor activation by asbestos in lung injury and disease. Int J Biochem Cell Biol 2003, 35:1198-1209. 10.1016/S1357-2725(02)00315-1, 12757757.
5. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677. 10.1126/science.1156995, 2396588, 18403674.
6. Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R. Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thoracic Oncol off Publ Int Assoc Study Lung Cancer 2012, 7:587-594.
7. Matsuzaki H, Maeda M, Lee S, Nishimura Y, Kumagai-Takei N, Hayashi H, Yamamoto S, Hatayama T, Kojima Y, Tabata R, Kishimoto T, Hiratsuka J, Otsuki T. Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis. J Biomed Biotechnol 2012, 2012:492608. 3304550, 22500091.
8. Hillegass JM, Miller JM, MacPherson MB, Westbom CM, Sayan M, Thompson JK, Macura SL, Perkins TN, Beuschel SL, Alexeeva V, Pass HI, Steele C, Mossman BT, Shukla A. Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Particle Fibre Toxicol 2013, 10:39.
9. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010, 11:136-140. 10.1038/ni.1831, 20023662.
10. Shukla A, Flanders T, Lounsbury KM, Mossman BT. The gamma-glutamylcysteine synthetase and glutathione regulate asbestos-induced expression of activator protein-1 family members and activity. Cancer Res 2004, 64:7780-7786. 10.1158/0008-5472.CAN-04-1365, 15520183.
11. Hillegass JM, Shukla A, MacPherson MB, Lathrop SA, Alexeeva V, Perkins TN, van der Vliet A, Vacek PM, Gunter ME, Mossman BT. Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells. Part Fibre Toxicol 2010, 7:26. 10.1186/1743-8977-7-26, 2945990, 20831825.
12. Holmgren A. Redox regulation by thioredoxin and thioredoxin reductase. Biofactors 2000, 11:63-64. 10.1002/biof.5520110117, 10705962.
13. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, Kim DK, Lee KW, Han PL, Rhee SG, Choi I. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000, 164:6287-6295. 10.4049/jimmunol.164.12.6287, 10843682.
14. Hwang J, Suh HW, Jeon YH, Hwang E, Nguyen LT, Yeom J, Lee SG, Lee C, Kim KJ, Kang BS, Jeong JO, Oh TK, Choi I, Lee JO, Kim MH. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein. Nat Commun 2014, 5:2958. 3941024, 24389582.
15. Shukla A, Bosenberg MW, MacPherson MB, Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR, Mossman BT. Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis. Am J Pathol 2009, 175:2197-2206. 10.2353/ajpath.2009.090400, 2774081, 19815709.
16. BeruBe KA, Quinlan TR, Fung H, Magae J, Vacek P, Taatjes DJ, Mossman BT. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am J Respir Cell Mol Biol 1996, 15:141-147.
17. Buder-Hoffmann S, Palmer C, Vacek P, Taatjes D, Mossman B. Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells. Am J Respir Cell Mol Biol 2001, 24:405-413. 10.1165/ajrcmb.24.4.4290, 11306433.
18. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, Powis G, Jones DP. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem 2003, 278:33408-33415. 10.1074/jbc.M211107200, 12816947.
19. Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Butnor KJ, Pass HI, Carbone M, Testa JR, Heintz NH, Mossman BT. ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. Int J Cancer 2011, 129:1075-1086. 10.1002/ijc.25763, 3071888, 21710492.
20. Hansen JM, Zhang H, Jones DP. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radic Biol Med 2006, 40:138-145. 10.1016/j.freeradbiomed.2005.09.023, 16337887.
21. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 2003, 34:1117-1129. 10.1016/S0891-5849(03)00060-1, 12706492.
22. Shukla A, Jung M, Stern M, Fukagawa NK, Taatjes DJ, Sawyer D, Van Houten B, Mossman BT. Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis. Am J Physiol Lung Cell Mol Physiol 2003, 285:L1018-L1025.
23. Sullivan DE, Ferris M, Pociask D, Brody AR. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol 2008, 5:145-149. 10.1080/15476910802085822, 18569384.
24. Srivastava RK, Lohani M, Pant AB, Rahman Q. Cyto-genotoxicity of amphibole asbestos fibers in cultured human lung epithelial cell line: role of surface iron. Toxicol Ind Health 2010, 26:575-582. 10.1177/0748233710374464, 20554628.
25. Ghio AJ, Stonehuerner J, Richards J, Devlin RB. Iron homeostasis in the lung following asbestos exposure. Antioxid Redox Signal 2008, 10:371-377. 10.1089/ars.2007.1909, 17999626.
26. Liu L, Elwing H, Karlsson A, Nimeri G, Dahlgren C. Surface-related triggering of the neutrophil respiratory burst. Characterization of the response induced by IgG adsorbed to hydrophilic and hydrophobic glass surfaces. Clin Exp Immunol 1997, 109:204-210. 10.1046/j.1365-2249.1997.4311329.x, 1904731, 9218845.
27. Taniguchi Y, Taniguchi Ueda Y, Mori K, Yodoi J. novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res 1996, 24:2746-2752. 10.1093/nar/24.14.2746, 145999, 8759006.
28. Das KC, Lewis-Molock Y, White CW. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol 1997, 17:713-726. 10.1165/ajrcmb.17.6.2809, 9409558.
29. Nickel W. The mystery of nonclassical protein secretion. A curr View Cargo Proteins Potential Export Routes Eur J Biochem 2003, 270:2109-2119.
30. Tanudji M, Hevi S, Chuck SL. The nonclassic secretion of thioredoxin is not sensitive to redox state. Am J Physiol Cell Physiol 2003, 284:C1272-C1279. 10.1152/ajpcell.00521.2002, 12529245.
31. Watanabe R, Nakamura H, Masutani H, Yodoi J. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther 2010, 127:261-270. 10.1016/j.pharmthera.2010.04.004, 20435060.
32. Hashemy SI, Holmgren A. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 2008, 283:21890-21898. 10.1074/jbc.M801047200, 18544525.
33. Nordberg J, Zhong L, Holmgren A, Arner ES. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 1998, 273:10835-10842. 10.1074/jbc.273.18.10835, 9556556.
34. Ishikawa A, Kubota Y, Murayama T, Nomura Y. Cell death by 1-chloro-2,4-dinitrobenzene, an inhibitor of thioredoxin reductase and its dual regulation by nitric oxide in rats. Neurosci Lett 1999, 277:99-102. 10.1016/S0304-3940(99)00850-2, 10624819.
35. Cenas N, Prast S, Nivinskas H, Sarlauskas J, Arner ES. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. J Biol Chem 2006, 281:5593-5603.
36. Seyfried J, Wullner U. Inhibition of thioredoxin reductase induces apoptosis in neuronal cell lines: role of glutathione and the MKK4/JNK pathway. Biochem Biophys Res Commun 2007, 359:759-764. 10.1016/j.bbrc.2007.05.176, 17559804.
37. Britt RD, Velten M, Locy ML, Rogers LK, Tipple TE. The Thioredoxin Reductase-1 Inhibitor Aurothioglucose Attenuates Lung Injury and Improves Survival in a Murine Model of Acute Respiratory Distress Syndrome. Antioxid Redox Signal 2013, Epub ahead of print February 6, 2014 doi:10.1089/ars.2013.5332. Online ahead of edits, December 2, 2013.
38. Zhang H, Du Y, Zhang X, Lu J, Holmgren A. Glutaredoxin2 Reduces both Thioredoxin2 and Thioredoxin1 and Protects Cells from Apoptosis Induced by Auranofin and 4-Hydroxynonenal. Antioxid Redox Signal 2013, Epub ahead of print February 4, 2014 doi:10.1089/ars.2013.5499. Online ahead of edits, December 2, 2013.
39. Shin HR, You BR, Park WH. PX-12-induced HeLa cell death is associated with oxidative stress and GSH depletion. Oncology letters 2013, 6:1804-1810. 3833989, 24260080.
40. Qiao Y, Wang P, Qi J, Zhang L, Gao C. TLR-induced NF-kappaB activation regulates NLRP3 expression in murine macrophages. FEBS Lett 2012, 586:1022-1026. 10.1016/j.febslet.2012.02.045, 22569257.
41. Gloire G, Piette J. Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid Redox Signal 2009, 11:2209-2222. 10.1089/ars.2009.2463, 19203223.
42. Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 2006, 25:6731-6748. 10.1038/sj.onc.1209936, 17072325.
43. Koharyova M, Kolarova M. Oxidative stress and thioredoxin system. Gen Physiol Biophys 2008, 27:71-84.